News Alert

House Subcommittee Clashes Over 340B Role in Drug Shortages

Rep. Cathy McMorris Rodgers
Legislation sponsored by Rep. Cathy McMorris Rodgers (R-Wash.) was the focus of a partisan clash during a Sept. 14 hearing over changes it would implement for the 340B program.
A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Coming Major GOP Healthcare Package Includes 340B Medicaid Provisions

A GOP bill expected to be introduced in the U.S. House contains provisions on Medicaid managed care 340B payments.
Republican House leaders were expected introduce—as soon as Sept. 8—and quickly advance a combined package of healthcare bills that includes [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Decision May Threaten Some State Health Plan Regulations, 340B Protections

A federal appeals court struck down parts of an Oklahoma PBM law, which could create a legal gray area for certain 340B protections.
A federal appeals court decision striking down parts of an Oklahoma pharmacy benefit manager (PBM) law could jeopardize state laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Provider Groups Oppose 340B Provisions in Committee Chair’s Drug Shortage Bill

House E&C wordmark
Provider groups criticized draft legislation to address drug shortages from the House Energy and Commerce Committee.
Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Claims Clearinghouse, Strengthening HRSA Among Few Consensus Areas in Responses to Senate 340B Overhaul Effort

Sen. John Thune
Sen. John Thune is part of a bipartisan group of six senators that solicited stakeholder advice on strategies to reform the 340B program.
The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House E&C GOP Leaders’ Draft Bill Would Exempt Sterile Generic Injectables from 340B Pricing Requirements

House Energy & Commerce Committee's draft bill.
GOP leaders on the House Energy & Commerce Committee released a draft bill to address drug shortages that includes a provision that would exempt certain drug products from 340B pricing requirements.
Republican leaders of the U.S. House Energy and Commerce (E&C) Committee released a draft bill late last week that would [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Panel Passes PBM Reform Bill With Medicaid Drug Payment Limits and 340B Reporting Requirements

Senate Finance Committee PBM reform bill markup.
The Senate Finance Committee voted 26-1 to pass a PBM reform bill with Medicaid spread pricing language that could result in less 340B savings for covered entities.
The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

100+ Health Centers and Groups Sign Pro-340C Letter to Congress

340C
More than 100 health centers and groups have signed a letter to Congress supporting the 340C initiative.
More than 100 community health centers, state primary care associations, and national and local groups urged congressional leaders this week [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Report Publisher and CEO to Providers: New 340B Reporting Requirements are Inevitable

Tim Walz
Minnesota became the first state to impose 340B reporting requirements after Gov. Tim Walz (D) signed legislation in late May.
Health care providers almost certainly will have to accept new 340B reporting requirements in order to get unfettered access to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Large Drug Maker, Big Health System, and Influential Health Center Jointly Lobbying for Senate Bipartisan 340B Initiative

340B Working Table 340B lobbying disclosure form
Under the name 340B Working Table, Genentech, Sanford Health, and Carolina Health Centers are jointly lobbying for a bipartisan U.S. Senate 340B reform initiative.

Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report